Next Science LLC
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$3.9M
Doctors Paid
3,820
Transactions
7,486
2024 Total
$821,456
Payment Breakdown by Category
Consulting$2.0M (51.6%)
Research$1.5M (38.1%)
Food & Beverage$327,421 (8.3%)
Travel$48,003 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2.0M | 110 | 51.6% |
| Unspecified | $1.5M | 218 | 38.1% |
| Food and Beverage | $327,421 | 7,037 | 8.3% |
| Travel and Lodging | $48,003 | 109 | 1.2% |
| Honoraria | $26,050 | 11 | 0.7% |
| Grant | $2,000 | 1 | 0.1% |
Payments by Type
General
$2.4M
7,268 transactions
Research
$1.5M
218 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| ISR-0104 | $240,768 | 0 | 7 |
| BlastX Vac Trial | $134,919 | 0 | 35 |
| Safety and Efficacy of BlastX in the Treatment of Mild to Moderate Distal Subungual Onychomycosis | $134,896 | 0 | 19 |
| evaluate the effect of Next Science acne cream on mild to moderate facial acne in females over 6 months | $134,006 | 0 | 21 |
| ISR-0101 | $61,545 | 0 | 5 |
| Wound Vac Study | $60,869 | 1 | 4 |
| Microbiome of Hidradenitis Suppurativa HS Tunneling Wounds | $57,710 | 0 | 5 |
| Clinical Assessment of the Effects of Next Science Wound Gel on Diagnostic Biopsy Wound Sites of Suspected Non Melanoma Skin Cancer Lesions | $52,678 | 0 | 32 |
| Evaluation of the impact of XPERIENCE on volumetric swelling following TKA | $50,176 | 0 | 4 |
| CSP-021 | $48,174 | 0 | 8 |
| CSP-018 | $42,271 | 0 | 30 |
| Toenail/DSO Study | $35,187 | 1 | 3 |
| Niezgoda Chronic Wound Study | $26,230 | 1 | 2 |
| Review of a Novel Antimicrobial Wound Gel System Used Protocols for the use of a novel biofilm disrupting wound irrigation solution | $20,000 | 0 | 1 |
| ISR-0102 | $17,272 | 0 | 4 |
| Microbiome of Hidradenitis Suppurativa (HS) Tunneling Wounds | $16,285 | 0 | 1 |
| Study Title is The microbiome of Hidradenitis Suppurativa tunneling wounds | $10,000 | 0 | 1 |
| ISR-0108 | $8,160 | 0 | 3 |
| Keloid Study | $5,895 | 1 | 3 |
| CSP-020 | $5,700 | 0 | 1 |
| ISR-0110 | $4,305 | 0 | 2 |
| ISR-0111 | $4,080 | 0 | 1 |
| ISR-0109 | $4,080 | 0 | 1 |
| CSP-013 | $2,882 | 0 | 1 |
| Icarus Study | $2,256 | 1 | 1 |
| CSP-019 | $1,500 | 0 | 1 |
| ISR-0106 | $900.00 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 152
No doctor payment records found.
About Next Science LLC
Next Science LLC has made $3.9M in payments to 3,820 healthcare providers, recorded across 7,486 transactions in the CMS Open Payments database. In 2024, the company paid $821,456. The top product by payment volume is SurgX ($1.7M).
Payments were distributed across 119 medical specialties. The top specialty by payment amount is Podiatrist ($691,012 to 504 doctors).
Payment categories include: Food & Beverage ($327,421), Consulting ($2.0M), Research ($1.5M), Travel & Lodging ($48,003).
Next Science LLC is associated with 6 products in the CMS Open Payments database, including SurgX, BlastX, and Xperience.